 | • レポートコード：QYR2104Z4020 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ナルコレプシーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（日中眠気、脱力発作、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ナルコレプシーの市場動向 ・企業の競争状況、市場シェア ・ナルコレプシーの種類別市場規模（日中眠気、脱力発作、その他） ・ナルコレプシーの用途別市場規模（病院、診療所、その他） ・ナルコレプシーの北米市場規模2016-2027（アメリカ、カナダ） ・ナルコレプシーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナルコレプシーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナルコレプシーの中南米市場規模2016-2027（メキシコ、ブラジル） ・ナルコレプシーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Jazz Pharmaceuticals、Bioprojet、Arena Pharmaceuticals、Graymark Healthcare、Mylan、Teva Pharmaceutical Industries、Novartis、Takeda、Shionogi、Ligand Pharmaceuticals） ・結論 |
Narcolepsy is a neurological disorder that affects the control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. These sudden sleep attacks may occur during any type of activity at any time of the day.
People with narcolepsy can be substantially helped, but not cured. Treatment is tailored to the individual, based on symptoms and therapeutic response. The time required to achieve optimal control of symptoms is highly variable and may take several months or longer. Medication adjustments are frequently necessary, and complete control of symptoms is seldom possible. While oral medications are the mainstay of formal narcolepsy treatment, lifestyle changes are also important.
Market Analysis and Insights: Global Narcolepsy Market
The global Narcolepsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Narcolepsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Narcolepsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Narcolepsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Narcolepsy market.
Global Narcolepsy Scope and Market Size
Narcolepsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Narcolepsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Daytime Extreme Sleepiness
Cataplexia
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Jazz Pharmaceuticals
Bioprojet
Arena Pharmaceuticals
Graymark Healthcare
Mylan
Teva Pharmaceutical Industries
Novartis
Takeda
Shionogi
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Narcolepsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Daytime Extreme Sleepiness
1.2.3 Cataplexia
1.2.4 Others
1.3 Market by Application
1.3.1 Global Narcolepsy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Narcolepsy Market Perspective (2016-2027)
2.2 Narcolepsy Growth Trends by Regions
2.2.1 Narcolepsy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Narcolepsy Historic Market Share by Regions (2016-2021)
2.2.3 Narcolepsy Forecasted Market Size by Regions (2022-2027)
2.3 Narcolepsy Industry Dynamic
2.3.1 Narcolepsy Market Trends
2.3.2 Narcolepsy Market Drivers
2.3.3 Narcolepsy Market Challenges
2.3.4 Narcolepsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Narcolepsy Players by Revenue
3.1.1 Global Top Narcolepsy Players by Revenue (2016-2021)
3.1.2 Global Narcolepsy Revenue Market Share by Players (2016-2021)
3.2 Global Narcolepsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Narcolepsy Revenue
3.4 Global Narcolepsy Market Concentration Ratio
3.4.1 Global Narcolepsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Narcolepsy Revenue in 2020
3.5 Narcolepsy Key Players Head office and Area Served
3.6 Key Players Narcolepsy Product Solution and Service
3.7 Date of Enter into Narcolepsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Narcolepsy Breakdown Data by Type
4.1 Global Narcolepsy Historic Market Size by Type (2016-2021)
4.2 Global Narcolepsy Forecasted Market Size by Type (2022-2027)
5 Narcolepsy Breakdown Data by Application
5.1 Global Narcolepsy Historic Market Size by Application (2016-2021)
5.2 Global Narcolepsy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Narcolepsy Market Size (2016-2027)
6.2 North America Narcolepsy Market Size by Type
6.2.1 North America Narcolepsy Market Size by Type (2016-2021)
6.2.2 North America Narcolepsy Market Size by Type (2022-2027)
6.2.3 North America Narcolepsy Market Size by Type (2016-2027)
6.3 North America Narcolepsy Market Size by Application
6.3.1 North America Narcolepsy Market Size by Application (2016-2021)
6.3.2 North America Narcolepsy Market Size by Application (2022-2027)
6.3.3 North America Narcolepsy Market Size by Application (2016-2027)
6.4 North America Narcolepsy Market Size by Country
6.4.1 North America Narcolepsy Market Size by Country (2016-2021)
6.4.2 North America Narcolepsy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Narcolepsy Market Size (2016-2027)
7.2 Europe Narcolepsy Market Size by Type
7.2.1 Europe Narcolepsy Market Size by Type (2016-2021)
7.2.2 Europe Narcolepsy Market Size by Type (2022-2027)
7.2.3 Europe Narcolepsy Market Size by Type (2016-2027)
7.3 Europe Narcolepsy Market Size by Application
7.3.1 Europe Narcolepsy Market Size by Application (2016-2021)
7.3.2 Europe Narcolepsy Market Size by Application (2022-2027)
7.3.3 Europe Narcolepsy Market Size by Application (2016-2027)
7.4 Europe Narcolepsy Market Size by Country
7.4.1 Europe Narcolepsy Market Size by Country (2016-2021)
7.4.2 Europe Narcolepsy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Narcolepsy Market Size (2016-2027)
8.2 Asia-Pacific Narcolepsy Market Size by Type
8.2.1 Asia-Pacific Narcolepsy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Narcolepsy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Narcolepsy Market Size by Type (2016-2027)
8.3 Asia-Pacific Narcolepsy Market Size by Application
8.3.1 Asia-Pacific Narcolepsy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Narcolepsy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Narcolepsy Market Size by Application (2016-2027)
8.4 Asia-Pacific Narcolepsy Market Size by Region
8.4.1 Asia-Pacific Narcolepsy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Narcolepsy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Narcolepsy Market Size (2016-2027)
9.2 Latin America Narcolepsy Market Size by Type
9.2.1 Latin America Narcolepsy Market Size by Type (2016-2021)
9.2.2 Latin America Narcolepsy Market Size by Type (2022-2027)
9.2.3 Latin America Narcolepsy Market Size by Type (2016-2027)
9.3 Latin America Narcolepsy Market Size by Application
9.3.1 Latin America Narcolepsy Market Size by Application (2016-2021)
9.3.2 Latin America Narcolepsy Market Size by Application (2022-2027)
9.3.3 Latin America Narcolepsy Market Size by Application (2016-2027)
9.4 Latin America Narcolepsy Market Size by Country
9.4.1 Latin America Narcolepsy Market Size by Country (2016-2021)
9.4.2 Latin America Narcolepsy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Narcolepsy Market Size (2016-2027)
10.2 Middle East & Africa Narcolepsy Market Size by Type
10.2.1 Middle East & Africa Narcolepsy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Narcolepsy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Narcolepsy Market Size by Type (2016-2027)
10.3 Middle East & Africa Narcolepsy Market Size by Application
10.3.1 Middle East & Africa Narcolepsy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Narcolepsy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Narcolepsy Market Size by Application (2016-2027)
10.4 Middle East & Africa Narcolepsy Market Size by Country
10.4.1 Middle East & Africa Narcolepsy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Narcolepsy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Jazz Pharmaceuticals
11.1.1 Jazz Pharmaceuticals Company Details
11.1.2 Jazz Pharmaceuticals Business Overview
11.1.3 Jazz Pharmaceuticals Narcolepsy Introduction
11.1.4 Jazz Pharmaceuticals Revenue in Narcolepsy Business (2016-2021)
11.1.5 Jazz Pharmaceuticals Recent Development
11.2 Bioprojet
11.2.1 Bioprojet Company Details
11.2.2 Bioprojet Business Overview
11.2.3 Bioprojet Narcolepsy Introduction
11.2.4 Bioprojet Revenue in Narcolepsy Business (2016-2021)
11.2.5 Bioprojet Recent Development
11.3 Arena Pharmaceuticals
11.3.1 Arena Pharmaceuticals Company Details
11.3.2 Arena Pharmaceuticals Business Overview
11.3.3 Arena Pharmaceuticals Narcolepsy Introduction
11.3.4 Arena Pharmaceuticals Revenue in Narcolepsy Business (2016-2021)
11.3.5 Arena Pharmaceuticals Recent Development
11.4 Graymark Healthcare
11.4.1 Graymark Healthcare Company Details
11.4.2 Graymark Healthcare Business Overview
11.4.3 Graymark Healthcare Narcolepsy Introduction
11.4.4 Graymark Healthcare Revenue in Narcolepsy Business (2016-2021)
11.4.5 Graymark Healthcare Recent Development
11.5 Mylan
11.5.1 Mylan Company Details
11.5.2 Mylan Business Overview
11.5.3 Mylan Narcolepsy Introduction
11.5.4 Mylan Revenue in Narcolepsy Business (2016-2021)
11.5.5 Mylan Recent Development
11.6 Teva Pharmaceutical Industries
11.6.1 Teva Pharmaceutical Industries Company Details
11.6.2 Teva Pharmaceutical Industries Business Overview
11.6.3 Teva Pharmaceutical Industries Narcolepsy Introduction
11.6.4 Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2016-2021)
11.6.5 Teva Pharmaceutical Industries Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Narcolepsy Introduction
11.7.4 Novartis Revenue in Narcolepsy Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 Takeda
11.8.1 Takeda Company Details
11.8.2 Takeda Business Overview
11.8.3 Takeda Narcolepsy Introduction
11.8.4 Takeda Revenue in Narcolepsy Business (2016-2021)
11.8.5 Takeda Recent Development
11.9 Shionogi
11.9.1 Shionogi Company Details
11.9.2 Shionogi Business Overview
11.9.3 Shionogi Narcolepsy Introduction
11.9.4 Shionogi Revenue in Narcolepsy Business (2016-2021)
11.9.5 Shionogi Recent Development
11.10 Ligand Pharmaceuticals
11.10.1 Ligand Pharmaceuticals Company Details
11.10.2 Ligand Pharmaceuticals Business Overview
11.10.3 Ligand Pharmaceuticals Narcolepsy Introduction
11.10.4 Ligand Pharmaceuticals Revenue in Narcolepsy Business (2016-2021)
11.10.5 Ligand Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Narcolepsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Daytime Extreme Sleepiness
Table 3. Key Players of Cataplexia
Table 4. Key Players of Others
Table 5. Global Narcolepsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Narcolepsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Narcolepsy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Narcolepsy Market Share by Regions (2016-2021)
Table 9. Global Narcolepsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Narcolepsy Market Share by Regions (2022-2027)
Table 11. Narcolepsy Market Trends
Table 12. Narcolepsy Market Drivers
Table 13. Narcolepsy Market Challenges
Table 14. Narcolepsy Market Restraints
Table 15. Global Narcolepsy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Narcolepsy Market Share by Players (2016-2021)
Table 17. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy as of 2020)
Table 18. Ranking of Global Top Narcolepsy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Narcolepsy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Narcolepsy Product Solution and Service
Table 22. Date of Enter into Narcolepsy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Narcolepsy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Narcolepsy Revenue Market Share by Type (2016-2021)
Table 26. Global Narcolepsy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Narcolepsy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Narcolepsy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Narcolepsy Revenue Market Share by Application (2016-2021)
Table 30. Global Narcolepsy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Narcolepsy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Narcolepsy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Narcolepsy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Narcolepsy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Narcolepsy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Narcolepsy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Narcolepsy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Narcolepsy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Narcolepsy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Narcolepsy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Narcolepsy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Narcolepsy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Narcolepsy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Narcolepsy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Narcolepsy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Narcolepsy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Narcolepsy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Narcolepsy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Narcolepsy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Narcolepsy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Narcolepsy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Narcolepsy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Narcolepsy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Narcolepsy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Narcolepsy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Narcolepsy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Narcolepsy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Narcolepsy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Narcolepsy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Narcolepsy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Narcolepsy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Jazz Pharmaceuticals Company Details
Table 63. Jazz Pharmaceuticals Business Overview
Table 64. Jazz Pharmaceuticals Narcolepsy Product
Table 65. Jazz Pharmaceuticals Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 66. Jazz Pharmaceuticals Recent Development
Table 67. Bioprojet Company Details
Table 68. Bioprojet Business Overview
Table 69. Bioprojet Narcolepsy Product
Table 70. Bioprojet Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 71. Bioprojet Recent Development
Table 72. Arena Pharmaceuticals Company Details
Table 73. Arena Pharmaceuticals Business Overview
Table 74. Arena Pharmaceuticals Narcolepsy Product
Table 75. Arena Pharmaceuticals Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 76. Arena Pharmaceuticals Recent Development
Table 77. Graymark Healthcare Company Details
Table 78. Graymark Healthcare Business Overview
Table 79. Graymark Healthcare Narcolepsy Product
Table 80. Graymark Healthcare Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 81. Graymark Healthcare Recent Development
Table 82. Mylan Company Details
Table 83. Mylan Business Overview
Table 84. Mylan Narcolepsy Product
Table 85. Mylan Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 86. Mylan Recent Development
Table 87. Teva Pharmaceutical Industries Company Details
Table 88. Teva Pharmaceutical Industries Business Overview
Table 89. Teva Pharmaceutical Industries Narcolepsy Product
Table 90. Teva Pharmaceutical Industries Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 91. Teva Pharmaceutical Industries Recent Development
Table 92. Novartis Company Details
Table 93. Novartis Business Overview
Table 94. Novartis Narcolepsy Product
Table 95. Novartis Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Takeda Company Details
Table 98. Takeda Business Overview
Table 99. Takeda Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 100. Takeda Recent Development
Table 101. Shionogi Company Details
Table 102. Shionogi Business Overview
Table 103. Shionogi Narcolepsy Product
Table 104. Shionogi Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 105. Shionogi Recent Development
Table 106. Ligand Pharmaceuticals Company Details
Table 107. Ligand Pharmaceuticals Business Overview
Table 108. Ligand Pharmaceuticals Narcolepsy Product
Table 109. Ligand Pharmaceuticals Revenue in Narcolepsy Business (2016-2021) & (US$ Million)
Table 110. Ligand Pharmaceuticals Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Narcolepsy Market Share by Type: 2020 VS 2027
Figure 2. Daytime Extreme Sleepiness Features
Figure 3. Cataplexia Features
Figure 4. Others Features
Figure 5. Global Narcolepsy Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Narcolepsy Report Years Considered
Figure 10. Global Narcolepsy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Narcolepsy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Narcolepsy Market Share by Regions: 2020 VS 2027
Figure 13. Global Narcolepsy Market Share by Regions (2022-2027)
Figure 14. Global Narcolepsy Market Share by Players in 2020
Figure 15. Global Top Narcolepsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Narcolepsy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Narcolepsy Revenue in 2020
Figure 17. Global Narcolepsy Revenue Market Share by Type (2016-2021)
Figure 18. Global Narcolepsy Revenue Market Share by Type (2022-2027)
Figure 19. North America Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Narcolepsy Market Share by Type (2016-2027)
Figure 21. North America Narcolepsy Market Share by Application (2016-2027)
Figure 22. North America Narcolepsy Market Share by Country (2016-2027)
Figure 23. United States Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Narcolepsy Market Share by Type (2016-2027)
Figure 27. Europe Narcolepsy Market Share by Application (2016-2027)
Figure 28. Europe Narcolepsy Market Share by Country (2016-2027)
Figure 29. Germany Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Narcolepsy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Narcolepsy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Narcolepsy Market Share by Region (2016-2027)
Figure 39. China Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Narcolepsy Market Share by Type (2016-2027)
Figure 47. Latin America Narcolepsy Market Share by Application (2016-2027)
Figure 48. Latin America Narcolepsy Market Share by Country (2016-2027)
Figure 49. Mexico Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Narcolepsy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Narcolepsy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Narcolepsy Market Share by Country (2016-2027)
Figure 55. Turkey Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Narcolepsy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Jazz Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 59. Bioprojet Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 60. Arena Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 61. Graymark Healthcare Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 63. Teva Pharmaceutical Industries Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 65. Takeda Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 66. Shionogi Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 67. Ligand Pharmaceuticals Revenue Growth Rate in Narcolepsy Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年） Narcolepsy is a chronic neurological disorder that is associated with Excessive Daytime Sleepiness (EDS), hypnagogic hallucinations, cataplexy, sleep paralysis, and fragmented night sleep. By therapeutic treatment, the global narcolepsy treatment market is segmented into central nervous system stimu…- 世界のナルコレプシー治療薬市場規模・現状・予測（2021年-2027年） Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme cases sometimes hours at one time. Market Analysis and Insights: Global Narcolepsy Therapeutics Mark…
- 世界の極端紫外線リソグラフィ（EUL）市場規模・現状・予測（2021年-2027年） Extreme ultraviolet lithography is a next-generation lithography technology using an extreme ultraviolet (EUV) wavelength, currently expected to be 13.5 nm. The market in APAC is likely to account for the largest share in 2018. Major drivers for the rapid growth of the EUV lithography market in APAC…
- 世界のコネクテッド医療機器セキュリティ市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Connected Medical Devices Security Market The global Connected Medical Devices Security market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high …
- 世界の動物病院・獣医クリニックサービス市場規模・現状・予測（2021年-2027年） Veterinary Clinic are those premises at which veterinary surgery is practiced, but at which animals are not retained overnight. In veterinary hospitals veterinary surgery is practiced and animals receive treatment, nursing care, and other services. Services in veterinary hospitals include reception,…